Acinetobacter baumannii is an opportunistic human pathogen that predominantly infects critically ill patients. Once thought to be benign, A. baumannii is now considered a global threat in the health-care setting, mainly due to its propensity to acquire multidrug, extensive drug and even pandrug resistance phenotypes at previously unforeseen rates 1, 2 . Infections caused by A. baumannii account for ~2% of all health-care-associated infections in the United States 3 and Europe 4 ; however, these rates are twice as high in Asia and the Middle East 4 . Although infection rates are lower than those caused by other Gramnegative patho gens, globally, ~45% of all isolates are considered to be multidrug-resistant (MDR), with rates as high as 70% in Latin America and the Middle East 1 . These daunting MDR rates are nearly four times higher than those observed for other Gram- Abstract | Acinetobacter baumannii is a nosocomial pathogen that causes ventilator-associated as well as bloodstream infections in critically ill patients, and the spread of multidrug-resistant Acinetobacter strains is cause for concern. Much of the success of A. baumannii can be directly attributed to its plastic genome, which rapidly mutates when faced with adversity and stress. However, fundamental virulence mechanisms beyond canonical drug resistance were recently uncovered that enable A. baumannii and, to a limited extent, other medically relevant Acinetobacter species to successfully thrive in the health-care environment. In this Review, we explore the molecular features that promote environmental persistence, including desiccation resistance, biofilm formation and motility, and we discuss the most recently identified virulence factors, such as secretion systems, surface glycoconjugates and micronutrient acquisition systems that collectively enable these pathogens to successfully infect their hosts.
. Infections caused by A. baumannii account for ~2% of all health-care-associated infections in the United States 3 and Europe 4 ; however, these rates are twice as high in Asia and the Middle East 4 . Although infection rates are lower than those caused by other Gramnegative patho gens, globally, ~45% of all isolates are considered to be multidrug-resistant (MDR), with rates as high as 70% in Latin America and the Middle East 1 . These daunting MDR rates are nearly four times higher than those observed for other Gram-negative pathogens, such as Pseudomonas aeruginosa and Klebsiella pneumoniae, for which global surveillance statistics are also available 1 . In light of this, the CDC categorized MDR Acinetobacter spp. as a serious threat, thus prompting continual public health monitoring and prevention activities 5 . Furthermore, the WHO has included carbapenem-resistant A. baumannii in the critical group in the list of bacteria that pose the greatest threat to human health, prioritizing research and development efforts for new antimicrobial treatments 6 .
A. baumannii causes a range of nosocomial infections across multiple anatomical sites 7 . Most commonly, A. baumannii infections manifest as ventilator-associated pneumonia or central-line-associated bloodstream infections 8 . Less frequently, A. baumannii causes infections in the skin and soft tissues and at surgical sites as well as catheter-associated urinary tract infections 8, 9 . Common to each of these scenarios is a breach in an anatomical barrier that enables the entry of A. baumannii directly to the site of infection. Community-acquired infections caused by A. baumannii have also been reported 10 . To date though, community-acquired infections have presented only in patients with underlying comorbidities, including alcohol use disorder, diabetes mellitus, cancer and obstructive pulmonary disorders 10 . Currently, there are more than 50 designated Acinetobacter species (List of Prokaryotic Names with Standing in Nomenclature), of which the overwhelming majority are considered nonpathogenic; however, as mentioned above, a select few species are opportunistic human pathogens. The most clinically relevant members of the Acinetobacter genus phylogenetically cluster into the Acinetobacter calcoaceticus-baumannii (Acb) complex 11 . The Acb complex consists of five pathogenic species: A. baumannii 12 , Acinetobacter nosocomialis 13 , Acinetobacter pittii 13 , Acinetobacter seifertii 14 and Acinetobacter dijkshoorniae 15 , as well as one nonpathogenic species, Acinetobacter calcoaceticus. The most clinically relevant and well-characterized Acinetobacter species is A. baumannii. This can be attributed to the inability to phenotypically distinguish A. baumannii from other members of the Acb complex, and until recently, this inability has hindered appropriate species identification. However, the use of matrix-associated laser desorp tion ionization-time of flight (MALDI-ToF) mass spectrometry to identify species-specific outer membrane components of each member of the Acb complex has greatly improved species identification 7, 16 . Nevertheless, given that all five pathogenic members of the Acb complex are frequently identified as A. baumannii, we will use the designation A. baumannii, unless otherwise stated, in the broad sense to encompass all pathogenic members of the Acb complex.
The genetic relatedness between members of the Acb complex and their phenotypical similarities might indicate that they share common virulence factors, rendering studies in A. baumannii potentially applicable to other pathogenic Acinetobacter species. Indeed, some clinically relevant and recently described virulence attributes of pathogenic Acinetobacter species were first described in A. nosocomialis and subsequently characterized in A. baumannii (discussed below). This is particularly relevant as many scientific studies focusing on the pathobiology of Acinetobacter species overwhelmingly use A. baumannii as the model organism. However, we are now starting to observe discrete clinical and phenotypic characteristics between members of the Acb complex, particularly A. baumannii, A. pittii and A. nosocomialis 17 .
Over the past decade, we have begun to unravel the exceptional and complex mechanisms that led to the emergence of A. baumannii as a formidable human pathogen, particularly beyond the canonical drug-resistance mechanisms that have been extensively studied. Although many common features emerge, there is a clear absence of any discernible toxin or molecular determinant that can account for the virulence potential of a particular A. baumannii strain. Instead, our current understanding of A. baumannii virulence suggests a 'persist and resist' strategy. Specifically, A. baumannii has a remarkable capacity to survive in unfavourable conditions. In this Review, we discuss our current understanding of the virulence mechanisms in A. baumannii. Particularly, we explore the molecular features that promote environmental persistence, including desiccation resistance, biofilm formation and motility, and we discuss the most recently identified virulence factors, such as secretion systems, surface glycoconjugates and micronutrient acquisition systems that facilitate A. baumannii pathogenesis. For a comprehensive review regarding the clinical and pathophysiological traits of A. baumannii, the reader is referred to a recently written article by experts in the field 18 .
Environmental persistence
It is largely believed that two attributes, drug resistance and environmental persistence, have enabled A. baumannii to thrive in the nosocomial environment 19 . Below, we discuss the features that enable A. baumannii to persist in environments that are inhospitable to many bacterial pathogens, thus setting the stage for human colonization and subsequent infection.
Mechanisms to resist disinfection, desiccation and oxidative stress. Commonly, health-care environments include prolonged periods of desiccation and routine disinfection regimes. Similar to antibiotic resistance, A. baumannii has adapted to those stresses 18 . Desiccation resistance, which is the ability to maintain viability under dry conditions, varies among clinical isolates of A. baumannii, with some isolates remaining viable for almost 100 days 20, 21 . Desiccation resistance in A. baumannii is multifactorial and not yet fully defined. However, it is clear that desiccation resistance depends on the ability of A. baumannii to maintain viability under conditions of water limitations. Indeed, in Acinetobacter baylyi, a nonpathogenic relative of A. baumannii, capsular polysaccharides promote survival during periods of desiccation 22 . These polysaccharides are composed of repeating carbohydrate units and function as a glycan shield that encompasses the entire bacterium and protects it from external threats. Although direct evidence is lacking, given the similar biosynthetic pathways for capsular polysaccharides in A. baylyi and A. baumannii 23 , the ability of the capsule to retain water in A. baumannii and the presence of a capsular polysaccharide covering in A. baumannii cells that are grown in a biofilm under dry conditions 24 , it is likely that the capsule contributes to the resistance to desiccation in A. baumannii. Furthermore, a recent study has linked desiccation resistance to the composition of the outer membrane 25 . Specifically, a mutant strain that produces underacylated lipooligosaccharide (LOS) was unable to survive periods of desiccation. The authors suggested that the increased membrane fluidity resulting from the altered lipid composition of the outer membrane in this mutant would likely permit leakage of water and hydrophilic nutrients out of the cell 25 . Remarkably, a recent study found that the total bacterial counts and total culturable counts of A. baumannii did not change during prolonged dry periods, which indicates that transitioning to a dormant state, defined by a substantial portion of the bacterial population entering a viable but nonculturable state, is not a major strategy for A. baumannii to persevere in desiccated environments 26 . However, the mechanisms behind desiccation persistence were not investigated and remain to be fully characterized.
Aside from the obvious loss of water during periods of desiccation, desiccation−rehydration causes various DNA lesions, including alkylation, oxidation, crosslinking, base removal and strand breaks 27 . To help prevent some of the DNA damage induced by desiccation− rehydration, A. baumannii relies on the protective role of the protein RecA 28 , which is an enzyme that is required for homologous recombination and recombination repair. A study showed an ~50-fold increase in the mutation frequency during a round of desiccation and rehydration of A. baumannii, as measured by the spontaneous appearance of rifampicin-resistant colonies 29 . This finding leads to the provocative hypothesis that resistance to desiccation may contribute to the MDR phenotype of A. baumannii.
Moreover, oxidative stress is also induced during periods of desiccation. As a result, A. baumannii substantially upregulates proteins that are associated with detoxifying reactive oxygen species 30 . Some Acinetobacter spp. are believed to have the highest tolerance to hydrogen peroxide beside spore-forming Gram-positive bacteria. A strain of Acinetobacter gyllenbergii is able to withstand 100 mM hydrogen peroxide with no loss in viability and
Two-component regulatory system
A two-part relay system used by bacteria for sensing and responding to environmental stimuli, consisting of a membrane-bound histidine kinase and a soluble response regulator.
maintains viability even in 320 mM hydrogen peroxide 31 . As A. gyllenbergii has been isolated from human specimens 32 , it is likely that more clinically relevant Acinetobacter spp., such as A. baumannii, will develop extremotolerances towards oxidative stressors given the genomic plasticity in members of the Acb complex. In fact, in response to oxidative stress, the emergence of A. baumannii strains that contain the insertion sequence element ISAba1 upstream of the catalase gene, katG, has been reported, which drives the expression of katG and enhances resistance to high levels of hydrogen peroxide 33 . However, more experimental evidence is warranted.
Disinfectants, such as chlorhexidine, are extensively used in hospitals and other health-care settings. Chlorhexidine, which is an antiseptic that is effective against Gram-negative and Gram-positive bacteria, disrupts cell membranes. A. baumannii has been shown to actively pump chlorhexidine out of the cell using the Acinetobacter chlorhexidine (AceI) efflux protein 34 , thus possibly promoting survival of the bacteria under stressful conditions. Another stressor, ethanol, has been shown to promote the growth and virulence of A. baumannii 35, 36 , albeit at low concentrations 37 . Moreover, physiological concentrations of ethanol found in the bloodstream of individuals with a history of alcohol use disorder sufficiently impair phagocytosis and thus elimination of A. baumannii 38 . In agreement with this, chronic alcohol consumption is one of the primary risk factors associated with community-acquired A. baumannii infections 10 . Although the role of environmental persistence has generally been accepted to be a virulence strategy of A. baumannii, much work is needed to determine the full underlying molecular mechanism.
Biofilm formation and maintenance. Microbial biofilms, which are communities that are encased in an extracellular matrix, are produced by many, if not all, bacteria. Biofilms are likely to have an important role in the interactions of A. baumannii with its host, and biofilm formation contributes to medical-device-associated infections.
During skin and soft-tissue infections, A. baumannii populations form robust biofilms, both in the wound and on occlusive dressings 39 . A. baumannii also forms biofilm communities on most abiotic surfaces, including health-care-associated equipment, such as endo tracheal tubes, as well as polycarbonate and stainless steel 40 . Notably, bacteria within biofilm communities, including A. baumannii, have increased tolerance to extracellular stresses 40, 41 . As with many biofilm-producing organisms, A. baumannii surface appendages, adhesins and protective surface structures, such as capsular polysaccharides, greatly contribute to the formation and maintenance of biofilms.
Although factors that contribute to biofilm formation seem to be strain-dependent, some common factors have been identified. Most A. baumannii strains encode and produce a type I chaperone-usher pilus system designated Csu pili (FIG. 1a) . Csu pili, which are regulated by the BfmRS two-component regulatory system 42 , are crucial for biofilm formation and maintenance on abiotic surfaces, including polystyrene 43 , but are not required for association with biotic surfaces, such as human epithelial cells 44 . Interestingly, most A. baumannii strains seem to carry the csuA/BABCDE locus; however, a subset of clinical isolates has lost the csu cluster 45 , which indicates that these pili may not be required for biofilm formation and maintenance in all strains or that other pili systems may functionally replace them (see below). Moreover, a second two-component system termed GacSA 46 has been shown to moderately control csu gene expression and thus indirectly biofilm formation. Interestingly, subinhibitory concentrations of trimethoprim−sulfamethoxazole have been shown to completely repress the expression of Csu pili in A. baumannii, which indicates that improper use of antibiotics can alter population-level behaviours and may promote a planktonic lifestyle 47 . Other putative chaperone-usher pili systems and Pap pili systems, which are homologous to the P pili of Escherichia coli, have been implicated in A. baumannii biofilm formation and maintenance, yet a detailed molecular analysis describing their specific role is lacking 48, 49 .
A. baumannii also produce biofilm-associated proteins (Bap Ab ) 50 , which are large surface-exposed proteins orthologous to the Bap protein originally characterized in Staphylococcus aureus 51 . Bap Ab , which is secreted via a type I secretion system (T1SS) 52 , mediates A. baumannii biofilm formation and maturation (FIG. 1a) . Specifically, Bap has a role in cell−cell adhesion and is required for the development of higher-order structures on medically relevant materials, such as polystyrene and titanium 50 . Although most sequenced strains of A. baumannii carry a bap gene, many seem to have disrupted or truncated bap sequences 53 .
It has yet to be determined if this is due to recombination events or sequence alignment errors common to the highly repetitive elements of bap coding sequences. Some A. baumannii strains also encode Bap-like proteins, BLP1 and BLP2, which coordinately contribute towards mature biofilm formation in a fashion similar to that of Bap Ab 54 . Finally, medically relevant Acinetobacter spp., including A. baumannii and A. nosocomialis, abundantly secrete a repeats in toxin (RTX)-like domain-containing protein through the T1SS 52 . This family of proteins is orthologous to large repetitive RTX domain-containing proteins found in Pseudomonas putida, which mediate biofilm development 55 . Other notable factors in A. baumannii that might be crucial for biofilm formation include the production of poly-β-1,6-N-acetylglucosamine (PNAG) 56 , which is produced by many Gram-negative species. Interestingly, antibodies against PNAG are able to eliminate A. baumannii in opsonophagocytosis assays, which suggests that PNAG might be a potential vaccine target 57 . Other factors that contribute to biofilm formation, such as capsular polysaccharides 58, 59 and an autotransporter system 60 , are discussed below.
Motility. In many different genera, bacterial motility is intimately linked with the ability of an organism to cause disease; for instance, in Pseudomonas aeruginosa, the flagellum functions as a key bacterial motor that is Surface-associated motility A mechanism of bacterial translocation observed on semisolid surfaces and unique to Acinetobacter spp., which is not dependent on pili.
Twitching motility
A mechanism of bacterial translocation dependent on repetitive rounds of type IV pili extension and retraction broadly used by many bacteria.
required for full virulence. In a related fashion, A. baumannii hypermotility has been associated with increased virulence in a Caenorhabditis elegans infection model 61 ; conversely, mutants defective in motility had an attenuated phenotype 62 . Furthermore, recent epidemiological studies of A. baumannii clinical isolates found that blood isolates were more motile than sputum isolates, indicating that motility may provide a fitness advantage in different anatomical sites 63 . Paradoxically, 'Acinetobacter' translates to 'nonmotile rod'; however, A. baumannii and A. nosocomialis strains are capable of two independent forms of bacterial locomotion: surface-associated motility and twitching motility. Twitching motility 64 is a well-described form of bacterial locomotion used by many genera of bacteria. In A. baumannii and A. nosocomialis, twitching motility is dependent on fully functioning type IV pili 65, 66 for repeated rounds of extension and retraction to pull bacterial cells forward. Although a direct link between type IV pili and/or twitching motility in virulence has not been observed for A. baumannii, genes predicted to encode proteins that are required for the biogenesis of type IV pili were shown to be upregulated during growth in human serum 67 , which indicates that type IV pili may be important during bacteraemia. Moreover, almost all A. baumannii and A. nosocomialis strains carry highly homologous genes encoding proteins that are required for the biogenesis of type IV pili. However, the major pilin subunit, fimbrial protein PilA, displays remarkable sequence divergence across species and even between strains. Structural analysis of two A. baumannii PilA proteins and an A. nosocomialis PilA protein showed that these sequence divergences manifest in a high degree of structural variation, much larger than expected for a given species 68 . As such, these sequence and structural variations make it likely that an A. baumannii type IV pilin-specific vaccine would fail.
Another form of motility, termed surface-associated motility, has also been observed in A. baumannii clinical isolates. The earliest reports of Acinetobacter spp. surface-associated motility ascribed the phenomenon to be dependent on twitching motility 69 . A subsequent study further strengthened these observations, as type IV pili retraction-deficient mutants in a strain of A. nosocomialis displayed impaired surface-associated motility 70 . A third study also observed that A. baumannii type IV pili retraction mutants had impaired surface-associated motility 65 . However, using the same A. nosocomialis strain, a contradictory report found that type IV pili do not have a role in surface-associated motility 66 . Specifically, it was found that A. nosocomialis mutants lacking functional type IV pili were unable to exhibit twitching motility yet displayed completely normal surface-associated motility.
A. baumannii surface-associated motility is most simi lar in appearance to the swarming motility of P. aeruginosa 71 , but swarming is dependent on flagella, and A. baumannii do not produce flagella. Currently, A. baumannii surface-associated motility has been shown to rely on the synthesis of 1,3-diaminopropane (DAP) 72 , quorum sensing 70 and LOS production 73 . It is possible that DAP or a derivative of DAP functions as a signalling molecule that is important for regulating surfaceassociated motility through quorum sensing. However, further work is needed to fully establish this mode of motility. Interestingly, A. baumannii surface-associated motility is repressed at room temperature in the presence of blue light, a feature that is dependent on proteins that Figure 1 | Protein secretion and export in Acinetobacter baumannii. Secretion systems and extracellular appendages of Acinetobacter baumannii are involved in the formation of biofilms, in virulence and in bacterial competition. a | The Csu system extrudes a type I chaperone--usher pilus that is essential for the formation and maintenance of biofilms on abiotic surfaces, which may contribute to persistence in hospital environments 43 . The CsuA/B, CsuA and CsuB pilin subunits are trafficked to the outer membrane CsuD usher by CsuC chaperones. The CsuD usher facilitates the polymerization of CsuA/B, CsuA and CsuB monomers into a pilin fibre. Pilin polymerization is initiated by the CsuE tip adhesion and the minor pilins CsuA and CsuB. Biofilm-associated proteins (Bap) 50 and an effector protein that contains a repeats in toxin (RTX)-like domain are secreted by the type I secretion system (T1SS) 52 and are involved in the formation and stability of mature biofilms. The T1SS is composed of the outer membrane protein TolC, the periplasmic adaptor protein hemolysin secretion protein D (HlyD) and the inner membrane ATPase HlyB. The Acinetobacter trimeric autotransporter (Ata) type Vc secretion system consists of a membrane-associated transporter domain and a large, repetitive passenger domain that extrudes through the transporter domain 60 . The adhesin promotes adherence to extracellular and basal membrane components of the host. b | The type II secretion system (T2SS) secretes multiple effectors that were shown to be required for virulence in vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA 103, 104 . Novel, dedicated chaperones are required for two of the effectors, including the Flp pilus assembly protein CpaB chaperone, which is required for the secretion of CpaA, the most abundant T2SS effector. A. baumannii and Acinetobacter nosocomialis also produce type IV pili, which are surface appendages that are evolutionarily related to the T2SS 66 . In A. baumannii and A. nosocomialis, these two systems share a processing protein, PilD, required to process pre-pseudopilins and pre-pilins before assembly into the T2SS and type IV pilus, respectively 104 . Type IV pili are also glycosylated in A. baumannii and A. nosocomialis as a possible form of antigenic variation to evade host detection. Specifically, the pilin glycan is predicted to mask the fimbrial protein PilA from antibody recognition; furthermore, PilA displays remarkable sequence divergence across species and even between strains, leading to reduced immune recognition if pilin subunits are not glycosylated 68 . c | Contact-dependent secretion systems are used by A. baumannii for interspecies and intraspecies killing to eliminate bacterial competitors. Many strains of Acinetobacter have two distinct contact-dependent inhibition (CDI) systems to kill sister cells that do not have the associated immunity protein (antitoxin) 52 . The type VI secretion system (T6SS) 106, 107 is used for interspecies competition and contains a novel L,D-endopeptidase, TagX, which is required for transit of the machinery through the peptidoglycan layer 128 . A large, conjugative plasmid, which also contains drug-resistance genes (not indicated), regulates the expression of T6SS in some clinical isolates 110 . The individual components of the secretion systems are indicated in all panels. Gsp, general secretion pathway protein.
▶ contain blue-light-sensing domains 74 . Finally, possible sources for the conflicting results described above are the phase-variable phenotypes of different A. baumannii and A. nosocomialis populations 75 . Specifically, a novel phase-variable colony opacity phenotype was discovered in A. baumannii strain AB5075, in which colonies interconvert between opaque and translucent variants. Interestingly, opaque phase variants have improved surface-associated motility and a concomitant improved virulence phenotype, whereas translucent variants are substantially less motile 76 . Thus, it is possible that the previously characterized type IV pili mutants, which displayed impaired surface-associated motility phenotypes, were immotile owing to a phase-variable phenomenon and not impairment or absence of type IV pili. Phase vari ation seems to be a common phenotype among most clinical isolates of A. baumannii, and this phenotype is likely to control additional virulence factors. This feature must be carefully considered when designing and performing experiments that assess the virulence and fitness of pathogenic Acinetobacter species 76 .
Interactions with hosts and competitors
Before the recent antibiotic resistance epidemic, A. baumannii was a scantly studied microorganism. In the past 10 years, many virulence factors have been uncovered and the innate immune response during an A. baumannii infection has been thoroughly characterized
. Virulence factors are broadly defined as molecular features used by a bacterium that enable successful interaction with and subsequent colonization of the human host. Given that nearly half of all A. baumannii infections are caused by MDR strains 1 , there is a need to accelerate investigations into its pathobiology to find alternative out-of-the-box strategies to combat A. baumannii infections 77 . Two main approaches have been used to discover A. baumannii virulence factors. The first, unbiased approach used high-throughput transposon screening to identify virulence factors under different experimental conditions. This approach has identified several candidate virulence factors, mainly predictable genes involved in cellular metabolism and cell envelope biogenesis. Although powerful, this strategy has not yet led to the identification of novel toxins or pathogenesis mechanisms. This could be due to the lack of an appropriate model that recapitulates human infections, the choice of the strains or experimental conditions or the fact that the defect in colonization by a particular mutant may be masked by the bacterial population as a whole. The second and most applied approach revolves around identifying homologous virulence mechanisms found in other human pathogens. This approach has led to the identification of protein glycosylation and secretion systems as well as the characterization of micronutrient acquisition mechanisms, which we discuss in the following section.
Glycoconjugates. Bacterial carbohydrates, also known as glycans, provide an interface between a pathogen and its environment. Not surprisingly, glycoconjugates have key structural roles and mediate the first line of defence against a variety of stresses, immune evasion and regulation and virulence in A. baumannii (FIG. 2) . Common bacterial glycoconjugates include the capsular polysaccharide, glycosylated proteins, lipopolysaccharide (LPS) and peptidoglycan.
LPS is a hallmark of Gram-negative bacteria and the ligand for Toll-like receptor 4 (TLR4). Similar to Neisseria and Campylobacter species, A. baumannii does not contain an O antigen; thus, its LPS is appropriately designated LOS. Regardless, in Gram-negative bacteria, LPS or LOS is the primary component of the outer leaflet of the outer membrane and as such is generally considered an essential structural component that is required for bacterial viability. Moreover, the lipid anchor of LPS and LOS, termed lipid A, is the target of the cationic polypeptide antibiotic colistin, which is a last-line treatment option for carbapenem-resistant A. baumannii 78 . Not surprisingly, A. baumannii isolates are adapting to this antibiotic in a multitude of ways (FIG. 3) . Similar to other Gram-negative bacteria, A. baumannii can modify its lipid A composition to deter the binding of colistin. Specifically, mutations in the PmrAB two-component system of A. baumannii mediate upregulation of pmrA expression 79 , which is accompanied by the addition of phosphoethanolamine to lipid A and increased resistance to colistin 80 . Epidemiological studies show that mutations in the pmrAB system are the most commonly observed mechanism for A. baumannii strains to become colistin resistant 45, 81 . Other lipid A modifications implicated Nature Reviews | Microbiology . These interactions, mediated through adhesins, such as the Acinetobacter trimeric autotransporter (Ata) 118 , type IV pili (TFP) 68 and biofilm-associated proteins (Bap) 119 , provide A. baumannii intimate contact with the host substratum (see the figure) . At the cell surface, key innate immune components known as pattern recognition receptors (PRRs) can then recognize specific pathogen-associated molecular patterns (PAMPs) of A. baumannii. The extracellular PRR Toll-like receptor 4 (TLR4), which recognizes lipid A of lipooligosaccharide (LOS), has a prominent signalling role, which helps to limit the A. baumannii burden in both pneumonic and systemic infection models. Although A. baumannii is considered an extracellular pathogen, it can invade epithelial cells using a zipper-like mechanism for uptake, which is dependent on both microfilaments and microtubules 120 . A. baumannii can persist in membrane-bound vacuoles in the cytoplasm, necessitating intracellular PRRs for pathogen detection. Indeed, signalling from the endolysosomal PRR, TLR9, which detects bacterial DNA, limits A. baumannii pneumonia and bacterial dissemination 121 . Furthermore, the cytosolic PRRs nucleotide-binding oligomerization domain-containing protein 1 (NOD1) and NOD2, as well as their downstream signalling partner receptor-interacting serine/threonine-protein kinase 2 (RIP2), limit intracellular A. baumannii proliferation in epithelial cells, which indicates that A. baumannii can escape membrane-bound vacuoles; however, its escape mechanisms are not yet known 122 . Ultimately, recognition by PRRs results in downstream signalling cascades mediated by the activation of nuclear factor-κB (NF-κB), the mitogen-activated protein kinase pathway and concomitant pro-inflammatory cytokine production that includes tumour necrosis factor (TNF), interleukin 6 (IL-6) and IL-8 (REFS 122, 123) .
Upon detection, epithelial cells secrete antimicrobial peptides, such as human β-defensin 2 and human β-defensin 3, which function as a first line of defence, inhibiting the growth of invading A. baumannii 123, 124 . Simultaneously, recruitment of phagocytic cells to the site of A. baumannii infection is mediated by cytokine and chemokine signalling. Neutrophils are the first to arrive and are the most important phagocytic cell type for controlling A. baumannii infections 114 . Indeed, antibody-mediated neutrophil depletion 125, 126 , which greatly enhances A. baumannii pathogenesis, results in severe mortality in experimental models. Mechanistically, neutrophil clearance of A. baumannii is mediated by the activity of the NADPH oxidase system, which generates reactive oxygen species (ROS) to kill phagocytosed bacteria 127 , with limited roles for reactive nitric species. Other phagocytic cells, such as macrophages and dendritic cells, have minor roles in A. baumannii clearance but may have important sensing and signalling roles.
Complement-mediated killing
A process that is part of the innate immune system consisting of soluble proteins in the blood that coordinately bind to an invading pathogen, triggering either lysis or the recruitment of immune cells to clear the pathogen.
O-glycosylation
The covalent attachment of a carbohydrate moiety to the hydroxyl group of a serine or threonine in a polypeptide.
in colistin resistance include the addition of galactosamine 82 and the natural presence of a predominately hepta-acylated form of LOS 25 . Colistin resistance is also mediated by the complete loss of LOS in A. baumannii 83 . This extreme adaption, which is conferred by mutations in lipid A biosynthetic genes, has been observed only in A. baumannii, Neisseria meningiditis and Moraxella catarhalis. Given its role in membrane integrity and stability, loss of lipid A, and thereby LOS, in A. baumannii requires compensatory mechanisms to support viability, such as the overexpression of certain lipoproteins as a form of outer membrane stabilization 84 . Another noted change in LOS-deficient strains includes an increase in the capsular polysaccharide PNAG 85 ; however, this compensatory mechanism has not been universally observed 84 . Most A. baumannii strains also carry a thick capsular polysaccharide 58 and an O-linked protein glycosylation system 59 . Capsular polysaccharides protect bacteria from external threats, including host defences. Protein glycosylation is the process of transferring a carbohydrate, usually an oligosaccharide, to a protein. In A. baumannii and A. nosocomialis, the capsular polysaccharide and the O-glycans that decorate proteins share a biosynthetic pathway 86, 87 . These processes start with the assembly of a lipid-linked oligosaccharide at the cytoplasmic side of the inner membrane. Once assembled, the lipid-linked oligosaccharide is flipped to the periplasmic side of the inner membrane. Upon reaching the periplasmic side, the lipidlinked oligosaccharide can be directly transferred to a protein by an oligosaccharyltransferase or further processed by the Wzy polymerase into repeating polysaccharide units, which are required for capsule biogenesis (FIG. 2) .
The capsular polysaccharide is mainly responsible for the extraordinary resistance to complement-mediated killing exhibited by most A. baumannii strains 58, 86 . In fact, the capsular polysaccharide of A. baumannii could be considered its main virulence factor as strains lacking the capsule are avirulent and readily killed by complement 86 . The glycans attached to proteins, which are most often located in the periplasm or the outer membrane and are exclusively membrane-associated in A. baumannii, are not involved in resistance to complement, but cells lacking the glycosylation system are defective in biofilm formation and are attenuated in several infection models, which indicates a role for protein glycosylation in the successful adaption to the host environment 59 . Moreover, most A. baumannii and A. nosocomialis strains contain two O-glycosylation systems: one system is responsible for glycosylation of multiple proteins of unknown function, and the other system has been implicated in the decoration of type IV pilin with glycans 87 (FIG. 2) . The biological role of protein glycosylation remains elusive; however, recent structural analyses and glycan modelling indicated that the pilin glycans may have evolved to shield the protein components from antigenic recognition 68 . Given the importance of capsular polysaccharides for A. baumannii virulence and the successful implementation of many capsular polysaccharide conjugate-based vaccines for the prevention of infection with Streptococcus pneumoniae, Haemophilus influenzae type B and N. meningiditis, an A. baumannii capsule-based conjugate vaccine initially seemed promising. Unfortunately, the variability among glycan structures, including capsule and glycoproteins, and the glycan core is outstanding . Glycan synthesis is initiated at the inner membrane by dedicated glycosyltransferases that transfer sugars to a phosphorylated lipid, generating a lipid-linked oligosaccharide (LLO). The LLO is then flipped to the periplasm, where the glycan component can be transferred by the O-oligosaccharyltransferase PglL to proteins in the periplasm or outer membrane or to type IV pilins by TfpO, a pilin-specific oligosaccharyltransferase. The LLO can also be further processed and polymerized into a repeating polysaccharide by the Wzy polymerase before transport to the outer membrane for capsule formation. In A. baumannii, the capsular polysaccharide protects cells from complement-mediated killing 58 . A. baumannii glycoproteins contribute to virulence by enhancing biofilm formation and maintenance 59 , whereas glycosylated type IV pilins 87 have been implied to function in immune evasion, shielding the antigenic protein from antibody recognition 68 . Finally, the hepta-acylated LOS, consisting of a core glycan and lipid A, lacks an O antigen but directly contributes to drug and desiccation resistance 25 . Nature Reviews | Microbiology and often includes sugars that have not previously been identified in any other species 23 . Clearly, this will make the formulation of an effective glycan-based vaccine difficult, if not impossible. Adding to the complexity, capsule synthesis can be increased upon contact with subinhibitory concentrations of antibiotics in a mechanism mediated by the two-component regulatory system BfmRS, which suggests that improper antibiotic therapy further enhances the virulence of A. baumannii 88 . Nevertheless, inhibitors of the glycan synthesis pathway would be highly valuable therapeutics to combat MDR A. baumannii infections.
Micronutrient acquisition systems.
Infecting the human host requires a coordinated response from A. baumannii that not only impairs cellular defence mechanisms, mainly in the form of protection via the capsular polysaccharide, but also enables metabolic and nutritional flexibility. Transition metals such as iron, manganese and zinc are essential for all domains of life; as such, hosts have evolved elaborate mechanisms to sequester metals, a process that is referred to as nutritional immunity. One key to the success of A. baumannii as a nosocomial pathogen is its diverse mechanisms for scavenging these scant nutrients in vivo. Indeed, highthroughput transposon screens identified mutants that contain transposon insertions within iron and zinc import and/or utilization genes, and these mutants were severely attenuated in virulence models [89] [90] [91] . The main mechanism used by A. baumannii for scavenging iron involves high-affinity iron chelating molecules known as siderophores. The most commonly conserved iron chelating agent in A. baumannii is the catechol-hydroxymate siderophore acinetobactin 92 . Depending on the pH of the extracellular environment, acinetobactin can isomerize into one of two forms, an oxazoline-containing or isooxazolidinone-containing form, both of which chelate iron 93 . This unique isomerization feature enables acinetobactin to bind iron under acidic conditions found during acute infections. Importantly, acinetobactin is absolutely required for virulence 94 , thus rendering its biosynthetic pathway an attractive antibacterial target. Other sets of catecholhydroxymate siderophores, fimsbactin A-F 95 , as well as the hydroxymate siderophores baumannoferrin A and baumannoferrin B 96 , are also iron scavengers used by A. baumannii; however, a detailed genetic and molecular analysis of their biosynthetic and transport machinery is lacking.
Zinc, which is a structural cofactor for many proteins, is also essential for the survival of A. baumannii. Given its essentiality to many bacterial pathogens, mammalian systems have evolved zinc sequestration mechanisms, including the production of the zinc chelating protein calprotectin 97 . Calprotectin production and release are robustly induced upon A. baumannii infection in the lungs of mice and persist for the entirety of the infection 98 . To combat calprotectin-mediated nutritional Nature Reviews | Microbiology , which is regulated by the PmrAB system. Moreover, the dual activity of the lipid A biosynthesis lauroyltransferase LpxM leads to the constitutive expression of a predominately hepta-acylated form of LOS, which provides increased resistance against colistin 25 . In extreme cases, A. baumannii will acquire mutations in the lipid A biosynthetic pathway, thereby halting its production 83 . In the absence of lipid A, A. baumannii has been shown to upregulate lipoproteins, namely, A1S_1944, A1S_1945 and A1S_2739, which stabilize the outer membrane 84 . The accumulation of the capsular polysaccharide poly-β-1,6-N-acetylglucosamine (PNAG) has also been observed in strains lacking lipid A as a proposed mechanism of membrane stabilization 
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immunity, A. baumannii relies on a high-affinity zinc acquisition system, termed ZnuABC 99 . The ZnuABC system is regulated by the zinc uptake regulation protein (Zur), which functions as a transcriptional repressor that binds to conserved DNA motifs upstream of many zinc-regulated genes, thus blocking their expression 100 . Under zinc-depleted conditions or in the presence of calprotectin, intracellular zinc levels decrease, and Zurmediated repression is relieved. A second zinc uptake system, also regulated by Zur, relies on the coordination between the metallochaperone ZigA and the histidine utilization (Hut) system for the uptake and release of histidine bound zinc (His−Zn) complexes 101 . In this system, the His−Zn complexes are imported by the outer membrane transporter HutT. Once inside A. baumannii cells, zinc is liberated from the His−Zn complexes to a bioavailable form with the coordination of ZigA and the histidine ammonia lyase, HutH. Similar to siderophores, zinc utilization systems are attractive antimicrobial targets given their importance in vivo and the lack of homologous systems in eukaryotic organisms.
Recently, the importance of the link between micronutrient acquisition and metabolism for A. baumannii virulence was shown. Specifically, A. baumannii subverts host-mediated metal limitation through the concerted action of a manganese import system and subsequent urea metabolism 102 . It is unclear why urea metabolism is important for A. baumannii growth under metal-limited conditions; however, it was speculated that metal limitation may cause a metabolic build-up of urea that requires manganese-mediated breakdown. Clearly, these types of studies show the importance of micronutrient acquisition systems to the virulence potential of A. baumannii and further emphasize the potential of those systems as novel antimicrobial targets. (FIG. 1) . For a detailed review of Acinetobacter spp. secretion systems and secreted proteins, the reader is referred to REF. 108 .
The first secretion system identified in A. baumannii was the adhesin Acinetobacter autotransporter (Ata) 60 , a type Vc trimeric autotransporter, which consists of a membrane-associated transporter domain and a large, repetitive passenger domain that extrudes through the transporter domain (FIG. 1a) . Ata is important for adhesion to host extracellular matrices and basal membrane components 60 . Ata is present in many clinical isolates and may be a potential vaccine candidate. Indeed, passive administration of anti-Ata serum protects neutropenic mice from infection 109 . However, Ata expression is variable among clinical isolates and thus may not provide adequate coverage for a comprehensive vaccine 60 .
A. baumannii and A. nosocomialis strains also use a type VI secretion (T6SS) system for bacterial competition 106, 107 (FIG. 1c) . This system is particularly important 110 . Specifically, two TetR-like regulators encoded on the plasmid repress T6SS activity, which is chromosomally encoded. Upon spontaneous loss of the plasmid, cells are relieved of T6SS repression and become potent bacterial killers. At the same time, cells that lost the plasmid now become susceptible to antibiotics, given that many resistance cassettes are located on the plasmid. This novel form of regulation may be altruistic as cells that lose the plasmid may be able to defend the entire bacterial population against competing bacteria in the polymicrobial environment. When antibiotics are introduced, cells that contain the plasmid survive and thus ensure the survival of the bacterial population.
A. baumannii and A. nosocomialis also use a type II secretion system (T2SS) for the export of multiple effector proteins 103, 104 (FIG. 1b) . Two of these effectors, the lipase LipA and the metalloprotease CpaA, require the dedicated chaperones LipB and CpaB, respectively, underscoring an under-recognized area of T2SS dynamics 104 . Previously, it was thought that the type III secretion system was the only secretion system that specifically used widespread chaperones for secreted effectors. Importantly, the A. baumannii and A. nosocomialis T2SSs function as bona fide virulence factors, secreting effectors that mediate colonization of the lung and dissemination to other organs. Moreover, it was recently shown that CpaA may be one of the main virulence factors secreted by the T2SS as a cpaA mutant was less viru lent in both an invertebrate model and a mouse model of pneumonia 111 . Interestingly, the cpaA mutant was less able to disseminate to the spleen. This may be due to the ability of CpaA to inhibit blood coagulation 112 , a process that may help A. baumannii to disseminate throughout the bloodstream to other anatomical sites, such as the spleen. However, the role of each specific effector, other than CpaA, in A. baumannii and A. nosocomialis pathogenesis remains elusive. Collectively, future studies are needed to define the secreted proteins that contribute to the success of A. baumannii as a nosocomial pathogen.
Conclusions and future perspectives
There are well over 2,000 A. baumannii genome sequences publicly available. Impressively, the paraloguecollapsed pan-genome size of A. baumannii reaches almost 12,000 sets of genes 113 . Furthermore, these types of analyses enable the mapping of the core A. baumannii genome. From this, the global distribution across A. baumannii strains and even A. nosocomialis strains of essential virulence factors, such as the capsular polysaccharide, secretion systems and micronutrient acquisitions systems, is readily identifiable. Together with the accumulation of resistance mechanisms, the success of A. baumannii as a nosocomial pathogen becomes evident. However, what if A. baumannii does acquire a toxin-like virulence factor similar to that of other human pathogens, such as Vibrio cholerae or Clostridium difficile? Molecular studies have shown that A. baumannii has many of the same secretion systems as other wellknown pathogens, and although there is no evidence to indicate such an acquisition, the possibility does exist.
In parallel, the emergence of MDR A. baumannii emphasizes the urgency of developing alternative treatment strategies. These anti-virulence strategies include phage-therapy, metabolic interference therapy, antimicrobial peptide therapy and vaccine strategies 77 . One such example would be targeting the phenylacetic acid (PAA) catabolic pathway with selective inhibitors, as PAA functions as a potent chemoattractant for neutrophils 114 . Recently, an A. baumannii mutant auxotrophic for d-glutamate was shown to be a very promising live attenuated vaccine candidate given its inability to synthesize mature peptidoglycan 115 .
Finally, it is clear that recent clinical isolates are genetically distinct from the type strains that are commonly used for scientific studies 45 . The two most frequently used strains, A. baumannii ATCC 17978 and A. baumannii ATCC 19606, have been excellent models for over two decades; however, both strains were isolated almost 70 years ago and do not adequately reflect clinical isolates that were recovered in the past three decades. As an example, A. baumannii ATCC 17978 carries the pAB3 plasmid, which is a large conjugative plasmid containing a single antibiotic resistance cassette. Over the course of 60 years, this plasmid has evolved into the pAB04 plasmid, which now contains 12 resistance cassettes in the same locus, indicating that antibiotic resistance has been positively selected. Another example is CpaA, which is commonly found in recent clinical isolates but is absent in both ATCC 17978 and ATCC 19606. Therefore, the use of modern clinical isolates, such as A. baumannii AB5075 (REF. 116 ), will provide a more contemporary understanding of the molecular mechanisms important for survival and adaption in this era and may lead to the identification of more relevant virulence factors outside of those involved in the persist and resist strategy commonly recognized as the only virulence mechanism of A. baumannii.
